cancer cells

Showing 1 posts of 1 posts found.

6188261_7290590b

GlaxoSmithKline acquires two solid tumor cell therapies from Immatics for $50 million

February 20, 2020
Business Services Cancer, cancer cells, celluar immunotherapies, immunotherapies

GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …

Latest content